for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cochlear Limited

COH.AX

現在値

212.18AUD

変化

-5.75(-2.64%)

出来高

237,955

本日のレンジ

211.64

 - 

219.96

52週レンジ

154.60

 - 

254.40

∙ 約20分前の相場を表示しています。

適時開示

Cochlear Ltd Posts First Quarter Trading Update

Oct 20 (Reuters) - Cochlear Ltd <COH.AX>::FIRST QUARTER TRADING UPDATE-COH.AX.Q1 COCHLEAR IMPLANT CONSTANT CURRENCY REVENUE WAS 94% OF Q1 LAST YEAR.FOR DEVELOPED MARKETS, COCHLEAR IMPLANT UNIT VOLUMES FOR Q1 EXPERIENCED LOW SINGLE‐DIGIT GROWTH.FOR EMERGING MARKETS, UNIT VOLUMES FOR Q1 WERE DOWN AROUND 40% ON Q1 LAST YEAR.SERVICES REVENUE CONTINUES TO RECOVER WITH Q1 ONSTANT CURRENCY REVENUE AT AROUND 86% OF Q1 LAST YEAR.

Cochlear Says No Net Profit Guidance Will Be Provided For FY21

Aug 18 (Reuters) - Cochlear Ltd <COH.AX>::NO NET PROFIT GUIDANCE WILL BE PROVIDED GIVEN UNCERTAINTY IN FORECASTING REVENUES FOR FY21.IN CONSIDERING USE OF CASH FOR FY21, FORECASTING AROUND $90 MILLION IN CAPITAL EXPENDITURE.AIMING TO GET REGULATORY APPROVAL FOR THE OSIA 2 SYSTEM IN EUROPE BY MID 2021.EXPECTS TO RESUME PAYMENT OF DIVIDEND ONCE A CLEAR & SUSTAINED IMPROVEMENT IN SALES REVENUE HAS BEEN ESTABLISHED.INVESTMENT IN RESEARCH AND DEVELOPMENT IS EXPECTED TO INCREASE TO AROUND $190‐195 MILLION IN FY21.

Cochlear Ltd reports FY Net Loss Attributable $238.3 Million Versus Profit Of $276.7 Million

Aug 17 (Reuters) - Cochlear Ltd <COH.AX>::COCHLEAR LTD - FY NET LOSS ATTRIBUTABLE $238.3 MILLION VERSUS PROFIT OF $276.7 MILLION.COCHLEAR LTD - FY SALES REVENUE DOWN 6% TO $1,352.3 MILLION.

Cochlear Says CFO Brent Cubis Tendered His Resignation

July 13 (Reuters) - Cochlear Ltd <COH.AX>::COCHLEAR- CFO BRENT CUBIS TENDERED HIS RESIGNATION, TO DEPART AT END OF CY.

Cochlear Obtains FDA Approval Of Kanso 2 Sound Processor

July 6 (Reuters) - Cochlear Ltd <COH.AX>::COCHLEAR OBTAINS FDA APPROVAL OF KANSO 2 SOUND PROCESSOR, FIRST OFF-THE-EAR COCHLEAR IMPLANT SOUND PROCESSOR WITH DIRECT SMARTPHONE CONNECTIVITY.COCHLEAR LTD - NEW PRODUCTS WILL BE COMMERCIALLY AVAILABLE IN U.S. AND CANADA LATER THIS YEAR.

Cochlear Says U.S. Court Denies Petition For Rehearing Of Appeal

May 19 (Reuters) - Cochlear Ltd <COH.AX>::US COURT OF APPEALS FOR FEDERAL CIRCUIT IN WASHINGTON, D.C. DENIED PETITION FOR REHEARING OF APPEAL.ANNOUNCES DENIAL OF APPEAL REHEARING IN U.S. PATENT INFRINGEMENT CASE.PAYMENT EXPECTED TO BE MADE IN CURRENT FY; COMMITTED BANK LOAN FACILITIES AVAILABLE TO FUND.

Cochlear Updates On Confirmation Of Covid-19 Pandemic Impact On Trading

May 11 (Reuters) - Cochlear Ltd <COH.AX>::COCHLEAR LTD- CONFIRMATION OF COVID-19 PANDEMIC IMPACT ON TRADING.COCHLEAR - SALES REVENUE ACROSS BUSINESS DECLINED BY ABOUT 60% IN APRIL COMPARED TO APRIL 2019.COCHLEAR - IN CHINA, SURGERIES RECOMMENCED IN LATE FEB & CONTINUED TO RECOVER THROUGHOUT APRIL.COCHLEAR- SERVICES BUSINESS ALSO IMPACTED WITH APRIL SALES DECLINING BY ABOUT 30%.COCHLEAR - REDUCED NON-ESSENTIAL SPENDING & CAPEX UNTIL THERE IS SUSTAINED INCREASE IN SURGERIES.COCHLEAR - EXPECTING GRADUAL RECOVERY WITH EXPECTATIONS THAT HOSPITALS WILL PROCEED CAUTIOUSLY WITH RESUMPTION OF ELECTIVE SURGERY.COCHLEAR- SUPPLY CHAIN CONTINUES TO BE LARGELY INTACT WITH NO SUPPLY SHORTAGES EXPECTED FOR COMPONENTS OVER COMING MONTHS.

Cochlear Says Decided To Increase SPP Offer Size To $220 Mln

April 28 (Reuters) - Cochlear Ltd <COH.AX>::COCHLEAR HAS DECIDED TO INCREASE SPP OFFER SIZE BY $170 MILLION TO $220 MILLION.INSTITUTIONAL PLACEMENT AND SPP HAVE RAISED A TOTAL OF $1.1 BILLION.INSTITUTIONAL PLACEMENT IN RESPONSE TO COVID-19 PANDEMIC.

FDA Expedites Approval Of Cochlear's Remote Check Solution For Cochlear Implants

April 7 (Reuters) - Cochlear Ltd <COH.AX>::FDA EXPEDITES APPROVAL OF COCHLEAR'S REMOTE CHECK SOLUTION FOR COCHLEAR IMPLANTS.COCHLEAR LTD - APPROVAL IS FIRST STEP IN COMMERCIALIZING PRODUCT OFFERING, WHICH IS ANTICIPATED BY END OF 2020.

Cochlear Says Non-Executive Directors To Take 30% Reduction In Board And Board Committee Fees

April 7 (Reuters) - Cochlear Ltd <COH.AX>::NON-EXECUTIVE DIRECTORS WILL TAKE A 30% REDUCTION IN BOARD AND BOARD COMMITTEE FEES.CEO & PRESIDENT DIG HOWITT WILL TAKE A 30% REDUCTION IN BASE SALARY.CEO & PRESIDENT DIG HOWITT WILL TAKE A 30% REDUCTION IN BASE SALARY.COCHLEAR LTD SAYS SENIOR EXECUTIVES WILL TAKE A 20% REDUCTION IN BASE SALARY.CEO & PRESIDENT DIG HOWITT WILL NOT RECEIVE ANY SHORT-TERM INCENTIVE FOR FY20.BUSINESS HAS ALSO IMPLEMENTED A HIRING FREEZE.COCHLEAR ANNOUNCES SHORT-TERM REDUCTION IN PAY FOR BOARD, CEO & PRESIDENT AND SENIOR EXECUTIVES FOR INITIAL PERIOD OF 3 MONTHS.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up